LYL1 (LYL1 basic helix-loop-helix family member) is a transcription factor that plays critical roles in hematopoiesis and leukemogenesis. As part of a heptad of transcription factors including FLI1, ERG, GATA2, RUNX1, TAL1, and LMO2, LYL1 binds regulatory elements in hematopoietic stem and progenitor cells (HSPCs), with distinct combinations enriched in lineage-specific regulatory elements 1. LYL1 functions through protein-protein interactions, forming complexes with LMO2 in myeloid leukemia cells where their expression mutually stimulates each other 2. In t(8;21) acute myeloid leukemia (AML), LYL1 facilitates AETFC complex assembly and gene activation by recruiting coactivator CARM1, contributing to leukemic cell survival 3. LYL1 is frequently overexpressed in pediatric AML and T-cell acute lymphoblastic leukemia, where it promotes cell growth and survival 45. During normal development, LYL1 can maintain primitive erythropoiesis and is a downstream target of SPI1 during endothelial-to-hematopoietic transition, specifically restoring lymphoid lineage potential 67. Paradoxically, in prostate cancer, LYL1 acts as a tumor suppressor mediating cellular senescence through a regulatory circuit involving BHLHE40 and p27kip1 8.